TY  - JOUR
AU  - DeFilipp, Z
AU  - Duarte, R F
AU  - Snowden, J A
AU  - Majhail, N S
AU  - Greenfield, D M
AU  - Miranda, J L
AU  - Arat, M
AU  - Baker, K S
AU  - Burns, L J
AU  - Duncan, C N
AU  - Gilleece, M
AU  - Hale, G A
AU  - Hamadani, M
AU  - Hamilton, B K
AU  - Hogan, W J
AU  - Hsu, J W
AU  - Inamoto, Y
AU  - Kamble, R T
AU  - Lupo-Stanghellini, M T
AU  - Malone, A K
AU  - McCarthy, P
AU  - Mohty, M
AU  - Norkin, M
AU  - Paplham, P
AU  - Ramanathan, M
AU  - Richart, J M
AU  - Salooja, N
AU  - Schouten, H C
AU  - Schoemans, H
AU  - Seber, A
AU  - Steinberg, A
AU  - Wirk, B M
AU  - Wood, W A
AU  - Battiwalla, M
AU  - Flowers, M E D
AU  - Savani, B N
AU  - Shaw, B E
PY  - 2016
DO  - 10.1038/bmt.2016.203
UR  - http://hdl.handle.net/10668/10380
T2  - Bone marrow transplantation
AB  - Metabolic syndrome (MetS) is a constellation of cardiovascular risk factors that increases the risk of cardiovascular disease, diabetes mellitus and all cause mortality. Long-term survivors of hematopoietic cell transplantation (HCT) have a...
LA  - en
PB  - Nature Publishing Group
KW  - Bone marrow
KW  - Prevalence
KW  - Consensus
KW  - Diabetes mellitus
KW  - Heart disease risk factors
KW  - Allografts
KW  - Cardiovascular diseases
KW  - Hematopoietic stem cell transplantation
KW  - Humans
KW  - Metabolic syndrome
KW  - Practice guidelines as topic
TI  - Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT.
TY  - research article
VL  - 52
ER  -